@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAbc3jRATDIYNgQ2WVRxHHyhq2Tv8MtbWKOoZbgG7PuO4> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAbc3jRATDIYNgQ2WVRxHHyhq2Tv8MtbWKOoZbgG7PuO4#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix rgd: <http://rgd.mcw.edu/rgdweb/report/gene/main.html?id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix hasAgent: <http://semanticscience.org/resource/SIO_000139> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 hasAgent: sub:_2;
    a go:0003824 .
  
  sub:_2 geneProductOf: rgd:62064;
    a Protein: .
  
  sub:_3 occursIn: obo:UBERON_0004237, species:10116;
    rdf:object sub:_1;
    rdf:predicate belv:directlyIncreases;
    rdf:subject schem:Norepinephrine;
    a rdf:Statement .
  
  sub:assertion rdfs:label "a(SCHEM:Norepinephrine) => cat(p(RGD:Adra1d))" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_6;
    pav:version "20131211" .
  
  sub:_4 dce:identifier "Cardiovascular Physiology Concepts";
    dce:title "Cardiovascular Physiology Concepts";
    dce:type "Other" .
  
  sub:_5 prov:value "There are several signal transduction mechanisms that modulate intracellular calcium concentration and therefore the state of vascular tone.  Three different mechanisms will be described here: 1) phosphatidylinositol pathway, 2) Gs-protein-coupled pathway, and 3) nitric oxide-cGMP pathway The phosphatidylinositol pathway (shown to the right) in VSM is similar to that found in the heart.  Norepinephrine (NE) acting via a1-adrenoceptors, angiotensin II (AII) acting via AII receptors, and endothelin-I (ET-1) acting through ETA receptors activate phospholipase C (PL-C) causing the formation of inositol triphosphate (IP3) from phosphatidylinositol (PIP2).";
    prov:wasQuotedFrom sub:_4 .
  
  sub:_6 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource sub:_4;
    prov:wasDerivedFrom beldoc:, sub:_5 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:31:29.046+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}